APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease

Journal of the American Society of Nephrology

Volumn 27, Issue 12, 2016, Pages 3600-3610

  Bruggeman, Leslie A ^a   Wu, Zhenzhen ^a   Luo, Liping ^a   Madhavan, Sethu M ^a   Konieczkowski, Martha ^a   Drawz, Paul E ^b   Thomas, David B ^c   Barisoni, Laura ^c   Sedor, John R ^a,d   O'Toole, John F ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN 1; COMPLEMENTARY DNA; NEPHRIN; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL DENSITY; ECLAMPSIA; FEMALE; FETUS DEATH; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; KIDNEY DISEASE; LITTER SIZE; MALE; MOUSE; NEWBORN DEATH; NONHUMAN; PHENOTYPE; PLACENTA; PODOCYTE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEINURIA; TRANSGENIC MOUSE; UREMIA; ANIMAL; DISEASE MODEL; GENETICS; PHYSIOLOGY;

ANIMALS; APOLIPOPROTEINS; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY DISEASES; LIPOPROTEINS, HDL; MICE; MICE, TRANSGENIC; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY;

EID: 85017205189     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015111220     Document Type: Article

References (59)

1. GenoveseG, FriedmanDJ, RossMD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845, 2010
2. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N,WasserWG, Behar DM, Skorecki K: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to theMYH9 gene. HumGenet 128: 345-350, 2010
3. Smith EE, Malik HS: The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res 19: 850-858, 2009
4. Thomson R, Genovese G, Canon C, Kovacsics D, Higgins MK, CarringtonM, Winkler CA, Kopp J, Rotimi C, Adeyemo A, Doumatey A, Ayodo G, Alper SL, Pollak MR, Friedman DJ, Raper J: Evolution of the primate trypanolytic factor APOL1. Proc Natl Acad Sci U S A 111: E2130-E2139, 2014
5. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A,Moguilevsky N, Dieu M, Kane JP, De Baetselier P, Brasseur R, Pays E: Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422: 83-87, 2003
6. Samanovic M, Molina-Portela MP, Chessler AD, Burleigh BA, Raper J: Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog 5: e1000276, 2009
7. Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC: Plasma apolipoprotein L1 levels do not correlate with CKD. J Am Soc Nephrol 25: 634-644, 2014
8. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J: Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.AmJ Transplant 15: 1615-1622, 2015
9. Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A: The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant 12: 1924-1928, 2012
10. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI: The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 11: 1025-1030, 2011
11. Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, Saleem MA, Satchell SC, Banas B, Mathieson PW, Kretzler M, Hemal AK, Rudel LL, Petrovic S, Weckerle A, Pollak MR, Ross MD, Parks JS, Freedman BI: Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. J Am Soc Nephrol 26: 339-348, 2015
12. Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR: APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 22: 2119-2128, 2011
13. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, SmithMC, Trachtman H, MichelDM, Schelling JR, VlahovD, PollakM,WinklerCA:APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
14. Limou S, Dummer PD, Nelson GW, Kopp JB,Winkler CA: APOL1 toxin, innate immunity, and kidney injury. Kidney Int 88: 28-34, 2015
15. Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstädt H, Kerjaschki D, Mizushima N, Shaw AS,Walz G, Huber TB: Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120: 1084-1096, 2010
16. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y: In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15: 1101-1111, 2004
17. Venkatareddy M, Wang S, Yang Y, Patel S, Wickman L, Nishizono R, Chowdhury M, Hodgin J, Wiggins PA, Wiggins RC: Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol 25: 1118-1129, 2014
18. Glassock RJ, Rule AD: The implications of anatomical and functional changes of the aging kidney:with an emphasis on the glomeruli. Kidney Int 82: 270-277, 2012
19. Zhao S, Gu X, Groome LJ, Wang Y: Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod Sci 16: 970-979, 2009
20. Beltcheva O, Kontusaari S, Fetissov S, Putaala H, Kilpeläinen P, Hökfelt T, Tryggvason K: Alternatively used promoters and distinct elements direct tissue-specific expression of nephrin.JAmSocNephrol 14: 352-358, 2003
21. Moeller MJ, Kovari IA, Holzman LB: Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 59 flanking region drives LacZ expression in podocytes. J Am Soc Nephrol 11: 2306-2314, 2000
22. Putaala H, Sainio K, SariolaH, Tryggvason K: Primary structure ofmouse and rat nephrin cDNA and structure and expression of themouse gene. J Am Soc Nephrol 11: 991-1001, 2000
23. Putaala H, Soininen R, Kilpeläinen P,Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8, 2001
24. Kuusniemi AM, Kestilä M, Patrakka J, Lahdenkari AT, Ruotsalainen V, Holmberg C, Karikoski R, Salonen R, Tryggvason K, Jalanko H: Tissue expression of nephrin in human and pig. Pediatr Res 55: 774-781, 2004
25. Palmén T, Ahola H, Palgi J, Aaltonen P, Luimula P, Wang S, Jaakkola I, Knip M, Otonkoski T, Holthöfer H: Nephrin is expressed in the pancreatic beta cells. Diabetologia 44: 1274-1280, 2001
26. Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR: The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 21: 1422-1426, 2010
27. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419, 2005
28. Kikuchi M, Wickman L, Hodgin JB, Wiggins RC: Podometrics as a Potential Clinical Tool for Glomerular Disease Management. Semin Nephrol 35: 245-255, 2015
29. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005
30. Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O'Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC: Glomerular Aging and Focal GlobalGlomerulosclerosis: A Podometric Perspective. J Am Soc Nephrol 26: 3162-3178, 2015
31. KimYH, GoyalM, Kurnit D,WharramB,Wiggins J, Holzman L, Kershaw D, Wiggins R: Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001
32. Hoy WE, Hughson MD, Kopp JB, Mott SA, Bertram JF, Winkler CA: APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study. J Am Soc Nephrol 26: 3179-3189, 2015
33. Oliveira Arcolino F, Tort Piella A, Papadimitriou E, Bussolati B, Antonie DJ, Murray P, van den Heuvel L, Levtchenko E: Human Urine as a Noninvasive Source of Kidney Cells. Stem Cells Int 2015: 362562, 2015
34. Lan X, Jhaveri A, Cheng K, Wen H, SaleemMA,Mathieson PW,Mikulak J, Aviram S, Malhotra A, Skorecki K, Singhal PC: APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol 307: F326-F336, 2014
35. Lan X, Wen H, Saleem MA, Mikulak J, Malhotra A, Skorecki K, Singhal PC: Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu. Exp Mol Pathol 98: 491-501, 2015
36. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA: Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem 283: 21540-21549, 2008
37. Cheng D, Weckerle A, Yu Y, Ma L, Zhu X,MureaM, Freedman BI, Parks JS, ShelnessGS: Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. J Lipid Res 56: 1583-1593, 2015
38. Heneghan JF, Vandorpe DH, Shmukler BE, Giovinnazo JA, Raper J, Friedman DJ, Pollak MR, Alper SL: BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins. Am J Physiol Cell Physiol 309: C332-C347, 2015
39. Nichols B, Jog P, Lee JH, Blackler D,WilmotM, D'Agati V,Markowitz G, Kopp JB, Alper SL, PollakMR, Friedman DJ: Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1. Kidney Int 87: 332-342, 2015
40. Khatua AK, CheathamAM, Kruzel ED, Singhal PC, Skorecki K, PopikW: Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1. Am J Physiol Cell Physiol 309: C22-C37, 2015
41. OlabisiOA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR: APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci U S A 113: 830-837, 2016
42. Dezso Z, Nikolsky Y, Sviridov E, ShiW, Serebriyskaya T, Dosymbekov D, Bugrim A, Rakhmatulin E, Brennan RJ, Guryanov A, Li K, Blake J, Samaha RR,Nikolskaya T: A comprehensive functional analysis of tissue specificity of human gene expression. BMC Biol 6: 49, 2008
43. She X, RohlCA, Castle JC, Kulkarni AV, Johnson JM,Chen R: Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics 10: 269, 2009
44. Duchateau PN, Pullinger CR, ChoMH, Eng C, Kane JP: Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. J Lipid Res 42: 620-630, 2001
45. Page NM, Butlin DJ, Lomthaisong K, Lowry PJ: The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74: 71-78, 2001
46. Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ: The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79: 539-546, 2002
47. Beall MH, Amidi F, Gayle DA, Wang S, Beloosesky R, Ross MG: Placental and fetal membrane Nephrin and Neph1 gene expression: response to inflammation. J Soc Gynecol Investig 12: 298-302, 2005
48. Li Y, Zheng R, Wang R, Lu X, Zhu C, Lin HY, Wang H, Yu X, Fu J: Involvement of nephrin in human placental trophoblast syncytialization. Reproduction 149: 339-346, 2015
49. Yun BH, Lee SM, Cho HY, Kim JY, Son GH, Kim YH, Park YW, Lim BJ, Kwon JY: Expression of nephrin in the human placenta and fetal membranes. Mol Med Rep 12: 5116-5120, 2015
50. Nakimuli A, Chazara O, Byamugisha J, Elliott AM, Kaleebu P, Mirembe F, Moffett A: Pregnancy, parturition and preeclampsia in women of African ancestry. Am J Obstet Gynecol 210: 510-520.e1, 2014
51. Shahul S, Tung A, Minhaj M, Nizamuddin J, Wenger J, Mahmood E, Mueller A, Shaefi S, Scavone B, Kociol RD, Talmor D, Rana S: Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia. Hypertens Pregnancy 34: 506-515, 2015
52. Elliott SE, Parchim NF, Liu C, Xia Y, Kellems RE, Soffici AR, Daugherty PS: Characterization of antibody specificities associated with preeclampsia. Hypertension 63: 1086-1093, 2014
53. Ruis-Gonz'lez MD, Cañete MD, Gómez-Chaparro JL, Abril N, Cañete R, López-Barea J: Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages. J Proteomics 119: 169-182, 2015
54. Wen Q, Liu LY, Yang T, Alev C, Wu S, StevensonDK, ShengG, Butte AJ, Ling XB: Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. PLoS One 8: e65571, 2013
55. Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE,Otto EA, Kopp JB, Randolph A, Vega-Warner V, Eichinger F,Nair V, Gipson DS, Cattran DC, Johnstone DB, O'Toole JF, Bagnasco SM, Song PX, Barisoni L, Troost JP, Kretzler M, Sedor JR: Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in BlackNEPTUNE Subjects [published online ahead of print July 6, 2015]. J Am Soc Nephrol 10.1681/ASN.2014111131
56. Ng DK, Robertson CC, Woroniecki RP, Limou S, Gilles CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG. APOL1-associated glomerular disease among African American children: A collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts. Nephrol Dialysis Transplant. in press.
57. Katsi V, Felekos I, Siristatidis C, Kasioni S, Drakontaidis A, Farmakides G, Makris T, Aggeli C, Nihoyannopoulos P, Tousoulis D, Kallikazaros I: Preeclampsia: What Does the Father Have to Do with It? Curr Hypertens Rep 17: 60, 2015
58. Eremina V, Wong MA, Cui S, Schwartz L, Quaggin SE: Glomerularspecific gene excision in vivo. J Am Soc Nephrol 13: 788-793, 2002
59. Barisoni L, Nast CC, Jennette JC, Hodgin JB, Herzenberg AM, Lemley KV, Conway CM, Kopp JB, Kretzler M, Lienczewski C, Avila-Casado C, Bagnasco S, Sethi S, Tomaszewski J, Gasim AH, Hewitt SM: Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol 8: 1449-1459, 2013